When patients cannot afford their medications, they may receive copay assistance from a pharmaceutical manufacturer or another third-party. Generally, the…
In November 2021, the Smarter Health Care Coalition (SHCC) sent a letter to the Department of the Treasury and the…
On December 9, 2021, ACTION for PDTs’ stakeholder group member, the Center for U.S. Policy (CUSP), presented at the Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC) meeting.…
On November 22, 2021, ACTION for PDTs hosted its first webinar Addressing Chronic Diseases, Mental Health, and Substance Use in America:…
On December 2, 2021, Aimed Alliance submitted a comment to the Centers for Medicare and Medicaid Services (CMS) urging them…
Aimed Alliance has published a new fact sheet titled IRS’s 2004 Notice Should Not Prevent Copay Accumulator Reform. The fact sheet reviews…
A 2021 study by Georgetown University Health Policy Institute Center found that during the COVID-19 special enrollment period online enrollment…
On November 12, 2021, the Centers for Medicare and Medicaid Services (CMS) announced that premiums for Medicare Part B would…
On November 1, 2021, the Alliance for Mental Healthcare Access (AMHCA) submitted a letter to Senator Ron Wyden and Senator…
A frequent criticism in the healthcare accessibility discussion is prescription drug pricing in the United States, and often the claim that prescription drug pricing is outpacing the cost of…